• About us
• Contact

Advertisement

Organisation › Details

Chemagen Biopolymer-Technologie AG

chemagen is a key player in the field of automated nucleic acid isolation. The purification of DNA, RNA, or viral DNA/RNA is facilitated through chemagen's proprietary M-PVA Magnetic Bead technology. chemagen's high performance instrument is the chemagic MSM I. It enables the automated separation of nucleic acids from sample volumes between 10 µl 10 ml. Kits are available for isolation and purification of nucleic acids from blood, serum/plasma, tissue, saliva, buccal swabs, amniotic fluid and feces. With the chemagic Prepito, chemagen offers a benchtop walk-away instrument relying upon the proven separation technology for up to 1000 µl sample material and 1 - 12 samples in parallel. Outstanding robustness, minimal hands-on time and fast automated applications translate to the highest throughput and flexibility of laboratory workflows. *

 

	Start	1997-12-01 splitoff
	End	renamed
	Group	PerkinElmer (Group)
	Today	PerkinElmer Chemagen Technologie AG
	Predecessor	RWTH Aachen (Rheinisch-Westfälische Technische Hochschule Aachen)
	Successor	PerkinElmer Chemagen Technologie AG
	Industry	BIOTECH
	Person	à Brassard, Lothar (Chemagen 201102 CEO)
	Region	Baesweiler
	Country	Germany
	Street	2 Arnold-Sommerfeld-Ring
	City	52499 Baesweiler
	Tel	+49-2401-805500
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for PerkinElmer (Group)

• [1] CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge....
• [2] PerkinElmer, Inc.. (6/22/21). "Press Release: PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader Sirion Biotech". Waltham, MA....
• [3] PerkinElmer, Inc.. (5/17/21). "Press Release: PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC". Waltham, MA....
• [4] Sirion Biotech GmbH. (1/7/21). "Press Release: Sirion Biotech GmbH Licensed Its LentiBoost Transduction Technology to Cellectis". Munich & Cambridge, MA....
• [5] Sirion Biotech GmbH. (10/6/20). "Press Release: Mustang Bio Licenses LentiBOOST Technology from Sirion Biotech for the Development of MB-207 Lentiviral Gene Therapy". Worcester, MA & Martinsried....
• [6] Rentschler Biopharma SE. (5/19/20). "Press Release: Rentschler Biopharma Licenses Horizon Discovery's CHOSource Platform to Complement Cell Line Development Offering for Difficult-to-Express Proteins". Laupheim, Milford, MA & Cambridge....
• [7] Sirion Biotech GmbH. (4/7/20). "Press Release: Beam Therapeutics Licenses Sirion Biotech’s LentiBOOST Technology for Its CAR-T pipeline". Martinsried....
• [8] PerkinElmer, Inc.. (8/21/19). "Press Release: PerkinElmer Announces Leadership Succession Plan". Waltham, MA....
• [9] Sirion Biotech GmbH. (7/31/19). "Press Release: Gene and Cell Therapy Solutions Provider, Sirion Biotech Announces Record First Half 2019 Financial Results". Munich....
• [10] PerkinElmer, Inc.. (7/24/19). "Press Release: PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market". Waltham, MA & Austin, TX....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.